November 27, 2014 5:45 AM ET

Pharmaceuticals

Company Overview of Optimer Pharmaceuticals, Inc.

Executive Profile

Robert Michael Savel II

Chief Technical Officer, Otonomy, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 4 different industries.

46--

Background

Mr. Robert Michael Savel, II, also kwon as Bob has been the Chief Technical Officer of Otonomy, Inc. since January 2014. Mr. Savel served as Chief Technical Officer and Senior Vice President of Inspire Pharmaceuticals, Inc. since September 2010. Mr. Savel served as Senior Vice President of Operations at Optimer Pharmaceuticals, Inc. since September 2011. He served as Senior Vice President of Manufacturing at Optimer Pharmaceuticals, Inc. since September 26, 2011, where ...

Corporate Headquarters

101 Hudson Street
Jersey City, New Jersey 07302

United States

Phone: 201-333-8819
Fax: 201-333-8870

Board Members Memberships

There is no Board Members Memberships data available.

Education

BS
Virginia Polytechnic Institute and State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Optimer Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.